While new drug discovery and development require significant time and resources, changing scientific, regulatory, and market conditions may create opportunities to accelerate the development process. Drug repurposing is an effective strategy that identifies new therapeutic applications for existing drugs, enabling faster development timelines by leveraging existing research, computational approaches, and contemporary repurposing tools.
At VIMTA, we are committed to supporting innovative scientific and business strategies that help transform existing molecules into new, enhanced, and differentiated therapeutic solutions.
Our approach combines published literature, established risk-benefit profiles, and strategically designed parallel studies to develop robust nonclinical programs that help reduce both short- and long-term development costs. During the nonclinical phase, we identify the most appropriate safety and efficacy studies to streamline product development and support regulatory submissions.
Our service offerings include:
- Strategic Planning and Scientific Rationale Establishment
- Bridging Studies Design
- Scientifically Driven Rationale Development for 505(b)(2) Filing
